Form 8-K - Current report:
SEC Accession No. 0001213900-20-008917
Filing Date
2020-04-09
Accepted
2020-04-09 17:30:20
Documents
52
Period of Report
2020-04-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea120559-8k_inmunebioinc.htm 8-K 26904
2 PRESENTATION ea120559ex99-1_inmunebio.htm EX-99.1 64696
3 SUMMARY ea120559ex99-2_inmunebio.htm EX-99.2 9756
4 GRAPHIC ex99-1_001.jpg GRAPHIC 157099
5 GRAPHIC ex99-1_002.jpg GRAPHIC 213539
6 GRAPHIC ex99-1_003.jpg GRAPHIC 159044
7 GRAPHIC ex99-1_004.jpg GRAPHIC 287946
8 GRAPHIC ex99-1_005.jpg GRAPHIC 342258
9 GRAPHIC ex99-1_006.jpg GRAPHIC 118269
10 GRAPHIC ex99-1_007.jpg GRAPHIC 134359
11 GRAPHIC ex99-1_008.jpg GRAPHIC 111672
12 GRAPHIC ex99-1_009.jpg GRAPHIC 94489
13 GRAPHIC ex99-1_010.jpg GRAPHIC 104128
14 GRAPHIC ex99-1_011.jpg GRAPHIC 124537
15 GRAPHIC ex99-1_012.jpg GRAPHIC 95790
16 GRAPHIC ex99-1_013.jpg GRAPHIC 133779
17 GRAPHIC ex99-1_014.jpg GRAPHIC 107908
18 GRAPHIC ex99-1_015.jpg GRAPHIC 148678
19 GRAPHIC ex99-1_016.jpg GRAPHIC 121315
20 GRAPHIC ex99-1_017.jpg GRAPHIC 142105
21 GRAPHIC ex99-1_018.jpg GRAPHIC 80678
22 GRAPHIC ex99-1_019.jpg GRAPHIC 131608
23 GRAPHIC ex99-1_020.jpg GRAPHIC 108904
24 GRAPHIC ex99-1_021.jpg GRAPHIC 78859
25 GRAPHIC ex99-1_022.jpg GRAPHIC 84387
26 GRAPHIC ex99-1_023.jpg GRAPHIC 134197
27 GRAPHIC ex99-1_024.jpg GRAPHIC 99464
28 GRAPHIC ex99-1_025.jpg GRAPHIC 99597
29 GRAPHIC ex99-1_026.jpg GRAPHIC 120897
30 GRAPHIC ex99-1_027.jpg GRAPHIC 122255
31 GRAPHIC ex99-1_028.jpg GRAPHIC 115255
32 GRAPHIC ex99-1_029.jpg GRAPHIC 150811
33 GRAPHIC ex99-1_030.jpg GRAPHIC 121139
34 GRAPHIC ex99-1_031.jpg GRAPHIC 117416
35 GRAPHIC ex99-1_032.jpg GRAPHIC 137084
36 GRAPHIC ex99-1_033.jpg GRAPHIC 113589
37 GRAPHIC ex99-1_034.jpg GRAPHIC 80382
38 GRAPHIC ex99-1_035.jpg GRAPHIC 92237
39 GRAPHIC ex99-1_036.jpg GRAPHIC 129929
40 GRAPHIC ex99-1_037.jpg GRAPHIC 134270
41 GRAPHIC ex99-1_038.jpg GRAPHIC 85869
42 GRAPHIC ex99-1_039.jpg GRAPHIC 139736
43 GRAPHIC ex99-1_040.jpg GRAPHIC 126894
44 GRAPHIC ex99-1_041.jpg GRAPHIC 133437
45 GRAPHIC ex99-1_042.jpg GRAPHIC 136354
46 GRAPHIC ex99-1_043.jpg GRAPHIC 122626
47 GRAPHIC ex99-1_044.jpg GRAPHIC 116748
48 GRAPHIC ex99-1_045.jpg GRAPHIC 132264
49 GRAPHIC ex99-1_046.jpg GRAPHIC 152753
50 GRAPHIC ex99-1_047.jpg GRAPHIC 141016
51 GRAPHIC ex99-2_001.jpg GRAPHIC 680598
52 GRAPHIC ex99-2_002.jpg GRAPHIC 535034
  Complete submission text file 0001213900-20-008917.txt   10235208
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 20785526
SIC: 2836 Biological Products, (No Diagnostic Substances)